Literature DB >> 15730486

Liver transplantation in hepatocellular carcinoma.

Josep Fuster1, Ramón Charco, Josep M Llovet, Jordi Bruix, Juan Carlos García-Valdecasas.   

Abstract

Liver transplantation is one option of surgical treatment for cirrhotic patients with hepatocellular carcinoma, it not only treats the malignancy but also the underlying disease. After an initial period of disappointing results, mainly due to lack of adequate selection, survival nowadays is similar to that obtained by cirrhotic patients without tumor. Currently the scarcity of donors is the main limitation in the treatment of this type of patients. Increased time on the waiting list does compromise the results if they are analyzed in an intention-to-treat basis. Adjuvant therapy on the waiting list (ethanol injection, chemoembolization, surgery, etc.) or the use of marginal grafts in order to increase the donor pool may be some alternatives to overcome this deficit. The development of adult living donor liver transplantation has proved to be a good alternative in this type of patients even if they do not fulfill the conventional criteria.

Entities:  

Mesh:

Year:  2005        PMID: 15730486     DOI: 10.1111/j.1432-2277.2004.00046.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  5 in total

1.  Comparison of Milan and UCSF criteria for liver transplantation to treat hepatocellular carcinoma.

Authors:  Tarkan Unek; Sedat Karademir; Naciye Cigdem Arslan; Tufan Egeli; Gulsen Atasoy; Ozgul Sagol; Funda Obuz; Mesut Akarsu; Ibrahim Astarcioglu
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

Review 2.  Management of "very early" hepatocellular carcinoma on cirrhotic patients.

Authors:  Gonzalo Sapisochin; Elena Fernandez de Sevilla; Juan Echeverri; Ramón Charco
Journal:  World J Hepatol       Date:  2014-11-27

3.  Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series.

Authors:  Gonzalo Sapisochin; Itxarone Bilbao; Joaquin Balsells; Cristina Dopazo; Mireia Caralt; Jose Luis Lázaro; Luis Castells; Helena Allende; Ramón Charco
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

4.  Correlationship between Ki67, VEGF, and p53 and Hepatocellular Carcinoma Recurrence in Liver Transplant Patients.

Authors:  Xia Zhang; Zhixian Wu; Yonghai Peng; Dongliang Li; Yi Jiang; Fan Pan; Yi Li; Yanhua Lai; Zhongyuan Cui; Kun Zhang
Journal:  Biomed Res Int       Date:  2021-04-15       Impact factor: 3.411

5.  Direct transdifferentiation of spermatogonial stem cells to morphological, phenotypic and functional hepatocyte-like cells via the ERK1/2 and Smad2/3 signaling pathways and the inactivation of cyclin A, cyclin B and cyclin E.

Authors:  Zhenzhen Zhang; Yuehua Gong; Ying Guo; Yanan Hai; Hao Yang; Shi Yang; Yang Liu; Meng Ma; Linhong Liu; Zheng Li; Wei-Qiang Gao; Zuping He
Journal:  Cell Commun Signal       Date:  2013-09-18       Impact factor: 5.712

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.